Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.460

0.0%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: MLD38	7/17/2007 4:45:10 PM
	of 368

Sangamo (SGMO) to sell 3,278,689 shrs @ $9.15 per shr biz.yahoo.com ...proceeds of $30 million before fees and expenses.... ...JMP Securities and Piper Jaffray & Co. are acting as joint lead placement agents... ...Leerink Swann & Co. and Janney Montgomery Scott are acting as co-placement agents.... ...The deal is expected to close July 20,... ...Sangamo announced on July 10 that it had signed a $13.75 million deal with Sigma-Aldrich Corp. of St. Louis to develop its zinc finger DNA-binding protein technology into products useful in research labs....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next